ReviewFrontiers in oncology2026
Towards ultra-fast treatments: large energy acceptance beam delivery systems and opportunities for proton beam therapy.
Review in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The availability of proton beam therapy (PBT) continues to grow exponentially worldwide, driven by technological advancements to reduce the facility size and costs, towards more efficient and higher quality treatments. The characteristic physical and biological advantages of protons can provide superior clinical outcomes for patients, as modern techniques enable a highly configurable and conformal dose delivery. Although active scanning methods allow precise beam control, proton beams are highly sensitive to range and motion errors which impact treatment quality. Treatment delivery is largely determined by capabilities of the beam delivery system (BDS), where faster delivery can have many potential benefits including improved dosimetric quality, utility, cost effectiveness, patient throughput and comfort. Despite significant developments in accelerators, delivery methodologies, dose optimisation and more, the energy layer switching time (ELST) is still a persisting limitation in existing beam delivery systems. The ELST can be a major contributor to the irradiation time, leading to increased treatment times, and may require further compensation using optimisation planning approaches, motion mitigation strategies, or active beam modification. This fundamental constraint can be addressed by increasing the narrow energy acceptance range of conventional beamlines to allow a wide range of beam energies to be transported without bottleneck delays due to magnetic field adjustments, therefore minimising ELSTs and enabling ultra-fast delivery (single field within ∼10 s). We review the abundant opportunities offered by this enabling technology: shorter treatment times, reduced motion induced dose degradation, improved effectiveness of motion management techniques, possibilities for volumetric rescanning, bidirectional delivery, novel planning optimisation schemes, and emerging delivery strategies. We overview the design concepts of several large energy acceptance (LEA) proposals, technology requirements, and also discuss the remaining challenges and considerations with realising a LEA system in practice. Although there are multiple avenues requiring further development and study, a large energy acceptance BDS has the potential for significant clinical benefits: ultra-fast delivery offers both immediate improvements to current treatment delivery and enables future possibilities for PBT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.